Navigation Links
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Date:5/23/2013

yalties on 8 of the top 20 selling pharmaceutical and biotech drugs by expected worldwide 2016 sales[1], and 9 products with over US$1 billion in annual sales.  These entities have a longer than fifteen year history of providing value to holders of royalty interests, including a US$400 million purchase of 80% of Memorial Sloan-Kettering Cancer Center's Neupogen®/ Neulasta® royalty, a US$525 million joint acquisition with Gilead Sciences of Emory University's emtricitabine royalty interest, a US$650 million purchase of New York University's Remicade® royalty, a US$700 million acquisition of AstraZeneca's Humira® royalty, a US$700 million purchase of a portion of Northwestern University's Lyrica® royalty, a US$609 million acquisition of Astellas Pharma's patent estate and associated royalty stream relating to the use of dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes including Januvia® and Janumet®, and most recently a US$761 million purchase of a portion of an interest in Biogen's recently approved Tecfidera (formerly BG-12) for the treatment of multiple sclerosis held by the former shareholders of Fumapharm AG.

FURTHER INFORMATION

The distribution of this announcement in, into, or from, certain jurisdictions other than Ireland, the United Kingdom and the United States may be restricted or affected by the laws of those jurisdictions.  Accordingly, copies of this announcement are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into, or from any such jurisdiction. Therefore persons who receive this announcement (including without limitation nominees, trustees and custodians) and are subject to the laws of any jurisdiction other than Ireland, the United Kingdom and the United States
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Royalty Pharma Announces Proposal To Acquire Elan
3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
8. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
9. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
10. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21. November 2014 Michael DeMarco ... Morgen des 14. Februar 2014 zugetragen hat. Seine Tochter ... vergessen. Video - http://youtu.be/5cVoMCe0uiE ... war, mein morgendliches Training zu machen", erzählt Michael ... der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war ...
(Date:11/21/2014)... BEVERLY HILLS, Calif. , Nov. 20, 2014 ... Ken Eaton , the election of Anthony J. ... as President. Effective November 19, 2014, ... and member of the Board of Directors of Oxis International, ... J. Cataldo has been named Chief Executive Officer of ...
(Date:11/21/2014)... THE WOODLANDS, Texas , Nov. 21, 2014 /PRNewswire/ ... announced that it has priced its offering of $80,000,000 ... 2021 (the "Convertible Notes") in a private offering within ... Notes were offered to qualified institutional buyers pursuant to ... amended (the "Securities Act"). Lexicon has also granted the ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3
... ARBOR, Mich., March 19, 2012 SARC, Sarcoma Alliance ... group, announced that on Tuesday, March 20, 2012, the ... Committee (ODAC) will review two New Drug Applications submitted ... for their drugs for the treatment of sarcoma.  Sarcoma ...
... March 19, 2012  BioDelivery Sciences International, Inc. (NASDAQ: ... Annual Report on Form 10-K for the year ended ... Commission and, in connection therewith, is providing a review ... operations and upcoming milestones for 2012. (Logo:  ...
Cached Medicine Technology:FDA's Oncologic Drugs Advisory Committee to Review Two New Drug Applications for Sarcoma on Tuesday, March 20, 2012 2BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 2BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 3BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 4BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 5BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 6BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 7BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report 8
(Date:11/22/2014)... Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that Ashley ... the Thanksgiving #PayItForward contest. , Ms. Lombardo entered ... from Kitchen Innovations. She wrote of how her friend ... young daughters as a single mom. Despite medical bills ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... 22, 2014 Developers and plugin specialist of ... entitled FCPX 3D Model bringing the impossible to FCPX ... users to add obj files to FCPX enabling 3d Model ... the line between professional and armature, FCPX 3D Model is ... Studios allows Final Cut Pro X users to upload and ...
(Date:11/22/2014)... 22, 2014 Wright & Schulte LLC ... lawsuits have been scheduled between October 2016 and ... of Illinois. U.S. District Judge Matthew F. Kennelly, who ... Management Order (CMO) on November 6, 2014 that outlined ... to submit documents and other activities in preparation for ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- A clinical ... anemia has been halted a year early because the ... to manage the disease and reduce the risk of ... conducted at 25 medical centers in the United States ... National Heart, Lung, and Blood Institute (NHLBI). Researchers ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... improved access to health education and benefits for ... seniors in communities across America, ... in Washington, D.C., CVS/pharmacy and the National Council on Aging,(NCOA) ... health and well-being of older Americans. Their joint,"Prescription for Better ...
... Batesville,Holdings, Inc., a wholly owned subsidiary of ... the present Batesville Casket Company,s funeral,services division, ... as Senior,Vice President Human Resources. He will ... human resources function for the new stand ...
... Accident Fund Insurance,Company of America has recognized Clark ... safe work environment. The company,recently surpassed 2 million ... 2006 the Michigan construction industry reported more,than 3,500 ... Construction,received the Gold Award from MIOSHA in 2005 ...
... ( http://www.nhs.uk ), the,digital ,front door, to the NHS, ... look after their foot health., Based on NHS ... find information about the importance of caring for your ... to treat them, plus how to,choose the correct footwear, ...
... Philadelphia City Council Acknowledges Department,s Anti-Violence,Program, ... Health and its partners were recognized today ... Injury Reporting and,Intervention System, or PIRIS, a ... Philadelphia., The system provides comprehensive intervention ...
... die from breast cancer each year because current treatments ... to stem the disease, warns Breast Cancer Campaign today. ... published today, 56 of the UKs most influential breast ... priorities for the greatest potential impact on patients. , ...
Cached Medicine News:Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 2Health News:CVS/pharmacy and the National Council on Aging Extend 'Prescription for Better Health' Partnership 3Health News:Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources 2Health News:Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources 3Health News:Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources 4Health News:Accident Fund Recognizes Clark Construction Co. for 2 Million Hours without a Lost-Time Injury 2Health News:Department of Health Highlights Violence as a Public Health Issue 2Health News:Too many women still dying from breast cancer, says charity 2
... system continues the "Consensus Concept" approach ... with the diversified experience of a ... an affordable knee system that incorporates ... designed to provide both joint and ...
... The Optetrak system includes a cruciate ... Patellar flange mates with both resurfacing ... assure precise, repeatable kinematics and fit ... to reduce wear. Constant cutting guide ...
... result of more than a decade of ... on a comprehensive study of knee kinematics ... tibial insert retrieval analysis.,As a result of ... and motion patterns in total knees, the ...
... The Foundation® PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
Medicine Products: